Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction
Edward Carter, Abbie E. Fearon, Richard Grose
Trends in Cell Biology (2014) Vol. 25, Iss. 4, pp. 221-233
Closed Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 600
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Masaru Katoh
International Journal of Molecular Medicine (2016) Vol. 38, Iss. 1, pp. 3-15
Open Access | Times Cited: 343
Genetic insights into the mechanisms of Fgf signaling
J. Richard Brewer, Pierre Mazot, Philippe Soriano
Genes & Development (2016) Vol. 30, Iss. 7, pp. 751-771
Open Access | Times Cited: 217
Therapeutics Targeting FGF Signaling Network in Human Diseases
Masaru Katoh
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 12, pp. 1081-1096
Closed Access | Times Cited: 187
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta, Paola Chiodelli, Arianna Giacomini, et al.
Pharmacology & Therapeutics (2017) Vol. 179, pp. 171-187
Closed Access | Times Cited: 183
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway
Piao Li, Tingting Huang, Qi Zou, et al.
The Journal of Immunology (2019) Vol. 202, Iss. 10, pp. 3065-3075
Closed Access | Times Cited: 149
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
Ruiwen Ruan, Li Li, Xuan Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 53
Roles of FGF Signals in Heart Development, Health, and Disease
Nobuyuki Itoh, Hiroya Ohta, Yoshiaki Nakayama, et al.
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 147
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications
Teresa Helsten, Maria Schwaederlé, Razelle Kurzrock
Cancer and Metastasis Reviews (2015) Vol. 34, Iss. 3, pp. 479-496
Open Access | Times Cited: 121
The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 121
Fibroblast growth factors as tissue repair and regeneration therapeutics
Quentin Nunes, Yong Li, Changye Sun, et al.
PeerJ (2016) Vol. 4, pp. e1535-e1535
Open Access | Times Cited: 104
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use
Harshnira Hitesh Patani, Tom D. Bunney, Nethaji Thiyagarajan, et al.
Oncotarget (2016) Vol. 7, Iss. 17, pp. 24252-24268
Open Access | Times Cited: 103
Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model
Davide Komla‐Ebri, Emilie Dambroise, Ina Krämer, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 5, pp. 1871-1884
Open Access | Times Cited: 101
Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis
Saïd C. Azoury, Sashank Reddy, Vivek Shukla, et al.
International Journal of Biological Sciences (2017) Vol. 13, Iss. 12, pp. 1479-1488
Open Access | Times Cited: 97
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Emmanuel Somm, François R. Jornayvaz
Endocrine Reviews (2018) Vol. 39, Iss. 6, pp. 960-989
Open Access | Times Cited: 94
Future applications of FGF/FGFR inhibitors in cancer
Gaia C. Ghedini, Roberto Ronca, Marco Presta, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 9, pp. 861-872
Closed Access | Times Cited: 89
Paracrine Effects of FGF23 on the Heart
Maren Leifheit‐Nestler, Dieter Haffner
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 88
FGF/FGFR signaling: From lung development to respiratory diseases
Lehe Yang, Feng Zhou, Dandan Zheng, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 62, pp. 94-104
Open Access | Times Cited: 79
The Multifunctional Contribution of FGF Signaling to Cardiac Development, Homeostasis, Disease and Repair
Farhad Khosravi, Negah Ahmadvand, Savério Bellusci, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 57
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 14
Dysregulated FGF signalling in neoplastic disorders
Yasmine Tanner, Richard Grose
Seminars in Cell and Developmental Biology (2015) Vol. 53, pp. 126-135
Closed Access | Times Cited: 70
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
Daniel Weekes, T G Kashima, Carolina Zandueta, et al.
Oncogene (2015) Vol. 35, Iss. 22, pp. 2852-2861
Open Access | Times Cited: 70
Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors
Anette Sommer, Charlotte Kopitz, Christoph A. Schatz, et al.
Cancer Research (2016) Vol. 76, Iss. 21, pp. 6331-6339
Open Access | Times Cited: 69
Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors
Bin Zhao, Yixuan Li, Pan Xu, et al.
ACS Medicinal Chemistry Letters (2016) Vol. 7, Iss. 6, pp. 629-634
Open Access | Times Cited: 65
Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
Sangwon Byun, Dong-Hyun Kim, Daniel Ryerson, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top